Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma

This study is currently recruiting participants.

Verified March 2013 by AIDS Malignancy Clinical Trials Consortium

Sponsor:

Collaborator:

Information provided by (Responsible Party):

AIDS Malignancy Clinical Trials Consortium

ClinicalTrials.gov Identifier:

NCT00598169

First received: January 9, 2008

Last updated: March 8, 2013

Last verified: March 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	November 2014
Estimated Primary Completion Date:	November 2013 (Final data collection date for primary outcome measure)